Copyright
©The Author(s) 2022.
World J Clin Cases. Oct 6, 2022; 10(28): 10017-10030
Published online Oct 6, 2022. doi: 10.12998/wjcc.v10.i28.10017
Published online Oct 6, 2022. doi: 10.12998/wjcc.v10.i28.10017
Table 3 Levels of insulin-like growth factor-1 receptor or P-glycoprotein expression in sera of patients with liver diseases
Group | n | IGF-1R (pg/mL) | P-gp (ng/mL) |
HCC | 93 | 758.6 ± 126.4 | 11.6 ± 5.1 |
Liver cirrhosis | 40 | 521.4 ± 78.3 | 7.3 ± 6.3 |
Chronic hepatitis | 40 | 456.8 ± 82.1 | 3.7 ± 1.4 |
Health control | 40 | 421.8 ± 58.6 | 1.0 ± 0.5 |
F value | 154.501 | 66.182 | |
q value1 | 0.689 | 0.487 | |
P value | < 0.001 | < 0.001 |
- Citation: Yao M, Cai Y, Wu ZJ, Zhou P, Sai WL, Wang DF, Wang L, Yao DF. Effects of targeted-edited oncogenic insulin-like growth factor-1 receptor with specific-sgRNA on biological behaviors of HepG2 cells. World J Clin Cases 2022; 10(28): 10017-10030
- URL: https://www.wjgnet.com/2307-8960/full/v10/i28/10017.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v10.i28.10017